(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 7854.22 | 11030.14 | -28.79 | 36165.28 | 44007.08 | -17.82 | 36165.28 | 44007.08 | -17.82 |
| Other Income | 389.39 | 652.34 | -40.31 | 2404.64 | 2239.40 | 7.38 | 2404.64 | 2239.40 | 7.38 |
| PBIDT | 2080.92 | 4136.65 | -49.70 | 12590.13 | 17345.79 | -27.42 | 12590.13 | 17345.79 | -27.42 |
| Interest | 21.81 | 20.32 | 7.33 | 74.14 | 52.40 | 41.49 | 74.14 | 52.40 | 41.49 |
| PBDT | 1494.50 | 4116.33 | -63.69 | 11951.38 | 17293.39 | -30.89 | 11951.38 | 17293.39 | -30.89 |
| Depreciation | 375.42 | 310.75 | 20.81 | 1467.36 | 1102.96 | 33.04 | 1467.36 | 1102.96 | 33.04 |
| PBT | 1119.08 | 3805.58 | -70.59 | 10484.02 | 16190.43 | -35.25 | 10484.02 | 16190.43 | -35.25 |
| TAX | 327.02 | 945.82 | -65.42 | 2725.76 | 4068.88 | -33.01 | 2725.76 | 4068.88 | -33.01 |
| Deferred Tax | -104.98 | 93.23 | -212.60 | -27.99 | 140.08 | -119.98 | -27.99 | 140.08 | -119.98 |
| PAT | 792.06 | 2859.76 | -72.30 | 7758.26 | 12121.55 | -36.00 | 7758.26 | 12121.55 | -36.00 |
| Equity | 164.70 | 164.30 | 0.24 | 164.70 | 164.30 | 0.24 | 164.70 | 164.30 | 0.24 |
| PBIDTM(%) | 26.49 | 37.50 | -29.35 | 34.81 | 39.42 | -11.68 | 34.81 | 39.42 | -11.68 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: